Categories
Biocon Limited — Important, 11-05-2026: Updates
11-05-2026 · 08:33 am
Biocon Pharma, a subsidiary, received Health Canada approval for Micafungin for injection (50/100 mg), used for Candidiasis. This approval expands Biocon's generics portfolio, enhancing its market position in biosimilars and generics.
No comments yet. Be the first to comment!